Lifecore Biomedical, Inc. \De\ (LFCR) Payables (2016 - 2025)
Historic Payables for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $8.2 million.
- Lifecore Biomedical, Inc. \De\'s Payables fell 4967.55% to $8.2 million in Q2 2025 from the same period last year, while for May 2025 it was $8.2 million, marking a year-over-year decrease of 4967.55%. This contributed to the annual value of $8.2 million for FY2025, which is 4967.55% down from last year.
- Lifecore Biomedical, Inc. \De\'s Payables amounted to $8.2 million in Q2 2025, which was down 4967.55% from $7.4 million recorded in Q1 2025.
- Lifecore Biomedical, Inc. \De\'s Payables' 5-year high stood at $22.1 million during Q2 2023, with a 5-year trough of $7.4 million in Q1 2025.
- Its 5-year average for Payables is $13.3 million, with a median of $13.3 million in 2022.
- Its Payables has fluctuated over the past 5 years, first plummeted by 8603.99% in 2021, then soared by 7060.69% in 2023.
- Lifecore Biomedical, Inc. \De\'s Payables (Quarter) stood at $8.7 million in 2021, then soared by 53.68% to $13.3 million in 2022, then soared by 43.02% to $19.0 million in 2023, then fell by 21.32% to $15.0 million in 2024, then tumbled by 45.08% to $8.2 million in 2025.
- Its Payables was $8.2 million in Q2 2025, compared to $7.4 million in Q1 2025 and $15.0 million in Q4 2024.